Showing results (31-40 of 84) with videos related to

Sort By:
Pageof 9
BMC Infectious Diseases|July 27, 2025
Co-infections during SARS-CoV-2 infection in hematologic patients and cell therapy recipients in the omicron era: a Spanish hematopoietic stem cell transplantation and cell therapy group studyPedro Chorão, Alex Avendaño, Inmaculada Heras, et al.
European Journal of Clinical Pharmacology|August 30, 2025
Validation of pharmacokinetic model for quizartinib quantified by UPLC-MS/MS in patients with FLT3-ITD negative newly diagnosed acute myeloid leukemiaAntonio Solana-Altabella, Carles Iniesta-Navalón, Maria Chovi-Trull, et al.
Leukemia & Lymphoma|December 12, 2018
Clinical significance of complex karyotype at diagnosis in pediatric and adult patients with de novo acute promyelocytic leukemia treated with ATRA and chemotherapyJorge Labrador, Elisa Luño, Edo Vellenga, et al.
Blood Advances|February 9, 2021
Measurable residual disease in elderly acute myeloid leukemia: results from the PETHEMA-FLUGAZA phase 3 clinical trialCatia Simoes, Bruno Paiva, David Martínez-Cuadrón, et al.
Plos One|February 13, 2016
Genome-Wide DNA Copy Number Analysis of Acute Lymphoblastic Leukemia Identifies New Genetic Markers Associated with Clinical OutcomeMaribel Forero-Castro, Cristina Robledo, Rocío Benito, et al.
Cancers|April 30, 2021
B-Cell Regeneration Profile and Minimal Residual Disease Status in Bone Marrow of Treated Multiple Myeloma PatientsRobéria Mendonça de Pontes, Juan Flores-Montero, Luzalba Sanoja-Flores, et al.
The Lancet Regional Health. Europe|May 21, 2026
Fosfomycin versus ciprofloxacin for febrile neutropenia prophylaxis in high-risk haematological patients (FOVOCIP): a phase 3, open-label, multicentre, randomised, non-inferiority trialAhinoa Fernández Moreno, Paula López de Ugarriza, Ana Julia González Huerta, et al.
Cancers|April 12, 2022
Use of Venetoclax in Patients with Relapsed or Refractory Acute Myeloid Leukemia: The PETHEMA Registry ExperienceJorge Labrador, Miriam Saiz-Rodríguez, Dunia de Miguel, et al.
Journal for Immunotherapy of Cancer|June 23, 2021
Circulating myeloid-derived suppressor cells and regulatory T cells as immunological biomarkers in refractory/relapsed diffuse large B-cell lymphoma: translational results from the R2-GDP-GOTEL trialCarlos Jiménez-Cortegana, Natalia Palazón-Carrión, Alejandro Martin Garcia-Sancho, et al.
Frontiers in Oncology|July 17, 2024
Omicron SARS-CoV-2 infection management and outcomes in patients with hematologic disease and recipients of cell therapyJosé Luis Piñana, Lourdes Vazquez, Inmaculada Heras, et al.
Pageof 9